Clinical trial
Correlation Study Between the Classification of Arthrogenic Motor Inhibition (AMI) and Clinical Assessment After ACL Rupture
NCT06945133 is registered in ClinicalTrials.gov with GCS Ramsay Santé pour l'Enseignement et la Recherche as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Correlation Study Between the Classification of Arthrogenic Motor Inhibition (AMI) and Clinical Assessment After ACL Rupture
- Lead sponsor
- GCS Ramsay Santé pour l'Enseignement et la Recherche
- Phase
- Not applicable
- Overall status
- Not yet recruiting
- Start date
- October 1, 2026
- Completion date
- April 30, 2028
- Enrollment
- 90 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
acl - anterior cruciate ligament rupture